Difference between revisions of "Clarithromycin (Biaxin)"
Jump to navigation
Jump to search
m |
m |
||
| Line 16: | Line 16: | ||
[[Category:Antibacterials]] | [[Category:Antibacterials]] | ||
| + | [[Category:Diffuse large B-cell lymphoma medications]] | ||
[[Category:MALT lymphoma medications]] | [[Category:MALT lymphoma medications]] | ||
[[Category:Multiple myeloma medications (historic)]] | [[Category:Multiple myeloma medications (historic)]] | ||
[[Category:FDA approved in 1991]] | [[Category:FDA approved in 1991]] | ||
Latest revision as of 19:05, 25 April 2022
Mechanism of action
Antibiotic which inhibits bacterial protein synthesis through binding to the 50S subunit. Mechanism for observed antineoplastic effect may be through suppression of IL-6.
Diseases for which it is used
Diseases for which it was used
Also known as
- Brand name: Biaxin